Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2026-01-04 @ 8:33 AM
Study NCT ID:
NCT02016105
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2013-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
Sponsor:
Sandoz
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-12
Start Date Type:
None
Primary Completion Date:
2015-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-02
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-14
First Submit QC Date:
None
Study First Post Date:
2013-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-22
Results First Submit QC Date:
None
Results First Post Date:
2017-04-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-04-06
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-04-24
Last Update Post Date:
2017-05-30
Last Update Post Date Type:
ACTUAL